| Date | Form | Description | Docs | XBRL | Pages |
| 09/07/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
33 |
| 06/11/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
34 |
| 03/09/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 09/08/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 05/26/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
32 |
| 03/16/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 08/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 05/20/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
34 |
| 02/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
30 |
| 08/18/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
37 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Read More...Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial
Read More...